Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice

NCT04243538 | Completed Results

• 2 other identifiers: 20-11022933frmrly19-04020138-11K76AG059997-01A1
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

With the growth of hospice, older adults have the opportunity to receive home-based care aimed at reducing suffering and focusing on quality of life at the end of life. While use of technology and educational videos has yet to be fully developed, structured, and evaluated in home hospice care, it has shown promise to improve care in other settings. Therefore, this study aims to develop and evaluate a multi-component technology-based care intervention, i.e., Improving Home hospice Management of End of life issues through technology (I-HoME).

Conditions

Hospice

Outcome Measures

Primary Outcomes (7)

• Participant Recruitment Rate

  Recruitment rate was measured by the number of participants consented divided by the number of eligible participants.

  During recruitment (22 months)

• Participant Attrition From Enrollment to End of Study

  This measure is the total number of participants who withdrew consent or were unreachable for study activities after consent.

  At the end of the intervention or at 6 weeks, which ever is earlier.

• Average Length of I-HoME Tele-visit

  This measure was collected by calculating the average duration (in minutes) of each tele-visit between the participant in I-HoME intervention arm and the interventionalist.

  At the end of the intervention or at 6 weeks, which ever is earlier.

• Total Number of Educational Videos Watched by I-HoME Intervention Arm Participants

  This measure is the total number of videos watched by the I-HoME intervention arm participants who received at least one tele-visit. Intervention arm participants self-reported whether they watched the educational videos recommended to them by the interventionist.

  At the end of the intervention or at 6 weeks, which ever is earlier.

• Number of I-HoME Intervention Caregivers Who Experienced Technical Issues During the Tele-visits.

  The number of I-HoME intervention caregivers who reported at least one technical issues with the tele-visit. Participants in the intervention arm answered questions about whether they experienced technical issues.

  At the end of the intervention or at 6 weeks, which ever is earlier.

• Percentage of Tele-visits With Hardware Issues Out of the Total Number of Tele-visit Intervention Visits

  After each intervention visit, participants answered questions about whether they experienced technical issues. This measure was calculated by dividing the number of I-HoME tele-visits during which the participant and/or the interventionist experienced hardware issues by the total number of I-HoME tele-visits administered during the entire study period.

  At the end of the intervention or at 6 weeks, which ever is earlier.

• Percentage of Tele-visits Conducted Out of the Total Possible Tele-visits.

  This measure is calculated by dividing the tele-visits conducted out of the total possible tele-visits. This measure shows the adherence of the I-HoME intervention arm to the tele-visits.

  At the end of the intervention or at 6 weeks, which ever is earlier.

Secondary Outcomes (2)

• Patients' Symptom Burden Score as Rated by the Caregiver, Measured at Baseline and Weekly for 6 Weeks.

  At baseline and weekly for 6 weeks.

• Number of Patient Hospitalizations From Enrollment to End of Intervention

  From enrollment to the end of the intervention or at 6 weeks, which ever is earlier.

Study Arms (2)

Control arm

NO INTERVENTION

Standard of care.

I-HoME intervention

EXPERIMENTAL

Weekly televisits with a nurse practitioner that will implement the I-HoME intervention.

Behavioral: I-HoME

Interventions

I-HoME BEHAVIORAL

I-HoME will consist of two components: (1) synchronous live video interactions between patients/CGs and a hospice nurse; and (2) educational videos.

I-HoME intervention

Eligibility Criteria

• Age: 18 Years - 110 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Home hospice caregivers must be:
• English speaking
• years of age or older
• not blind
• having a family member receiving home hospice care
• Home hospice patients must be:
• English speaking
• years of age or older
• not blind
• enrolled in home hospice care.

You may not qualify if:

• Patients with a terminal diagnosis of dementia or patients who have cognitive impairment and unable to sign a written informed consent will be excluded.

Sponsors & Collaborators

• Weill Medical College of Cornell University: lead
• National Institute on Aging (NIA): collaborator
• Visiting Nurse Service of New York: collaborator

Study Sites (1)

The Visiting Nurse Service of New York

New York, New York, 10017, United States

Location

Results Point of Contact

• Title: Dr. Veerawat Phongtankuel
• Organization: Weill Cornell Medicine

vep9012@med.cornell.edu

212-746-7000

Study Officials

• Veerawat Phongtankuel, MD, MS

  Weill Medical College of Cornell University

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 23, 2020
• First Posted: January 28, 2020
• Study Start: February 14, 2022
• Primary Completion: October 10, 2024
• Study Completion: October 10, 2024
• Last Updated: August 7, 2025
• Results First Posted: August 7, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)